Drug development is a multi-step process involving the discovery, design, testing, and approval of new pharmaceutical compounds intended for therapeutic use. It begins with the identification of potential drug targets, followed by the creation of drug candidates through medicinal chemistry or biotechnology. The process typically includes preclinical studies, where safety and efficacy are assessed in laboratory and animal studies, and clinical trials, which involve testing the drug in humans across multiple phases to evaluate its safety, efficacy, dosage, and potential side effects. Upon successful completion of these phases, a new drug application can be submitted to regulatory authorities, such as the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA), for approval to market the drug. Drug development is a complex, time-consuming, and costly endeavor that may take several years, often requiring significant investment and collaboration among various stakeholders, including pharmaceutical companies, regulatory bodies, and clinical researchers.
Exploring the Role of Artificial Intelligence in Drug Discovery The integration of artificial intelligence into drug discovery offers a potential game changer, but opinions are incredibly mixed. While some industry…